Newer Therapies in Acne Management Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Newer Therapies in Acne Management. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Newer Therapies in Acne Management Indian Medical PG Question 1: In which of the following conditions is phototherapy, specifically ultraviolet light therapy, useful for treatment?
- A. Psoriasis (Correct Answer)
- B. Tinea corporis
- C. Pemphigus
- D. PMLE
Newer Therapies in Acne Management Explanation: ***Psoriasis***
- **Phototherapy** (narrowband UVB, broadband UVB, or PUVA) is a **well-established first-line treatment** for **moderate-to-severe psoriasis**.
- It works by **suppressing overactive immune cells** in the skin, reducing inflammation and decreasing keratinocyte proliferation.
- **Direct therapeutic effect** on active psoriatic lesions makes this the primary indication for phototherapy in dermatology.
*Tinea corporis*
- **Tinea corporis** is a **superficial fungal infection** (dermatophytosis) of the skin.
- Requires **antifungal medications** (topical azoles or oral terbinafine/griseofulvin) for treatment.
- **Phototherapy has no antifungal activity** and is not used for this condition.
*Pemphigus*
- **Pemphigus** is an **autoimmune blistering disease** with intraepidermal acantholysis.
- Treatment requires **systemic immunosuppression** (corticosteroids, rituximab, azathioprine).
- **Phototherapy is not indicated** and could potentially worsen the condition.
*PMLE*
- **Polymorphous light eruption (PMLE)** is a common **photosensitivity disorder**.
- While **prophylactic photohardening** (gradual controlled UV exposure) can be used to build tolerance **before sun exposure season**, this is a **preventative desensitization strategy**, not treatment of active disease.
- Unlike psoriasis, phototherapy does **not treat active PMLE lesions** and can trigger flares if not done properly.
- The primary approach for active PMLE is **sun avoidance, sun protection, and topical corticosteroids**.
Newer Therapies in Acne Management Indian Medical PG Question 2: Which hormone is responsible for acne?
- A. Gonadotropins
- B. Testosterone (Correct Answer)
- C. Estrogen
- D. Thyroid
Newer Therapies in Acne Management Explanation: ***Testosterone***
- **Testosterone** is an **androgen** that stimulates the **sebaceous glands** in the skin, leading to increased **sebum production**.
- Excessive sebum, along with dead skin cells and bacteria, can clog pores and cause **acne breakouts**.
*Gonadotropins*
- **Gonadotropins (LH and FSH)** regulate the function of the gonads (testes and ovaries) and **indirectly influence sex hormone production**.
- They do not directly cause acne; their role is upstream in the **hypothalamic-pituitary-gonadal axis**.
*Estrogen*
- **Estrogen** generally has an **anti-androgenic effect**, and its presence can sometimes **improve acne**, especially in women.
- High levels of estrogen or estrogen therapy are often used to treat hormonally-driven acne.
*Thyroid*
- **Thyroid hormones** (T3 and T4) regulate metabolism and play a role in skin health, but they are **not directly responsible for acne**.
- Imbalances in thyroid hormones can affect skin texture, but **acne is not a primary symptom of thyroid dysfunction**.
Newer Therapies in Acne Management Indian Medical PG Question 3: Benzoyl peroxide acts in acne vulgaris by:
- A. Decreasing bacterial count (Correct Answer)
- B. Reduces sebum production
- C. Acts as a keratolytic agent
- D. Increases epithelial turnover
Newer Therapies in Acne Management Explanation: ***Decreasing bacterial count***
- **Benzoyl peroxide** is a highly effective topical treatment for acne primarily due to its potent **antimicrobial activity** against *Cutibacterium acnes*, the bacterium implicated in acne pathogenesis.
- It works by releasing **free radicals** that disrupt bacterial cell membranes and metabolism, thereby reducing the bacterial load in follicles.
*Reduces sebum production*
- While sebaceous gland activity is critical in acne, benzoyl peroxide does **not directly reduce sebum production**; retinoids like isotretinoin are known for this effect.
- Its primary action is focused on combating bacteria and mildly promoting desquamation rather than affecting **lipid synthesis**.
*Acts as a keratolytic agent*
- Benzoyl peroxide does possess some **keratolytic activity**, aiding in the shedding of dead skin cells and preventing pore blockage.
- However, its keratolytic action is **less pronounced** compared to agents like salicylic acid or tretinoin, and it is not its primary mechanism of action.
*Increases epithelial turnover*
- While benzoyl peroxide does promote a mild increase in **epithelial cell turnover**, helping to clear clogged pores, it is not its main mechanism of action or defining characteristic.
- **Topical retinoids** (e.g., tretinoin, adapalene) are far more effective and primarily used to normalize follicular keratinization and increase cell turnover.
Newer Therapies in Acne Management Indian Medical PG Question 4: An adolescent male presents with severe acne lesions and sinus tracts. Which is the most effective drug for this condition?
- A. Minocycline
- B. Doxycycline
- C. Isotretinoin (Correct Answer)
- D. Topical dapsone
Newer Therapies in Acne Management Explanation: ***Isotretinoin***
- This patient presents with **severe acne**, likely cystic or nodular, given the mention of "sinus tracts," which often correlates with **acne conglobata**.
- **Isotretinoin** is the most effective treatment for severe acne as it targets all four pathogenic factors of acne: **sebaceous gland activity**, **follicular hyperkeratinization**, *C. acnes* proliferation, and inflammation.
*Minocycline*
- Minocycline is an **oral antibiotic** used for moderate to severe inflammatory acne, primarily due to its anti-inflammatory properties and ability to reduce *C. acnes*.
- While effective for some inflammatory acne, it is **less effective than isotretinoin** for severe, nodulocystic acne or acne with sinus tracts and is not a definitive cure.
*Doxycycline*
- Doxycycline is another **oral tetracycline antibiotic** commonly used for moderate to severe inflammatory acne due to its anti-inflammatory effects and reduction of *C. acnes*.
- Similar to minocycline, it is a good option for inflammatory acne but **insufficient for very severe, recalcitrant acne** with sinus tracts, where isotretinoin is superior.
*Topical dapsone*
- Topical dapsone is an **anti-inflammatory agent** primarily used for mild to moderate inflammatory acne, particularly papules and pustules.
- It is **not effective for severe nodulocystic acne** or acne associated with sinus tracts and would not be appropriate as monotherapy for this presentation.
Newer Therapies in Acne Management Indian Medical PG Question 5: Which is not used in acne?
- A. Doxycycline
- B. Ampicillin (Correct Answer)
- C. Clindamycin
- D. Erythromycin
Newer Therapies in Acne Management Explanation: ***Ampicillin***
- **Ampicillin** is a penicillin-class antibiotic primarily used for bacterial infections like respiratory tract infections, urinary tract infections, and meningitis; it has no significant role in the treatment of acne.
- Its spectrum of activity and mechanism do not target the specific processes involved in **acne pathophysiology**, such as reducing *Propionibacterium acnes (P. acnes)* growth or inflammation relevant to acne.
*Doxycycline*
- **Doxycycline** is a tetracycline antibiotic commonly used in acne treatment due to its anti-inflammatory properties and its ability to inhibit the growth of *P. acnes*.
- It reduces sebum production and targets inflammatory lesions, making it effective for **moderate to severe inflammatory acne**.
*Clindamycin*
- **Clindamycin** is a lincosamide antibiotic often used topically for acne due to its effectiveness against *P. acnes* and its anti-inflammatory effects.
- It helps reduce bacterial load on the skin and diminish the inflammatory response associated with acne lesions.
*Erythromycin*
- **Erythromycin** is a macrolide antibiotic that can be used topically or orally for acne due to its ability to kill *P. acnes* and its anti-inflammatory properties.
- It is an alternative for patients who cannot tolerate tetracyclines or for whom other treatments are not effective, though **bacterial resistance** has limited its use.
Newer Therapies in Acne Management Indian Medical PG Question 6: Treatment of choice for Nodulocystic Acne is:
- A. Isotretinoin (Correct Answer)
- B. Erythromycin
- C. PUVA
- D. Tetracycline
Newer Therapies in Acne Management Explanation: ***Isotretinoin***
- **Isotretinoin** is a systemic retinoid that targets all four major pathogenic factors of acne: **sebum production**, **follicular hyperkeratinization**, **Propionibacterium acnes growth**, and **inflammation**.
- It is considered the most effective medication for **severe, nodulocystic acne**, often leading to long-term remission.
*Erythromycin*
- **Erythromycin** is a topical or oral antibiotic primarily used for its antibacterial and anti-inflammatory properties against *P. acnes*.
- While useful for milder inflammatory acne, it is generally **insufficient for severe nodulocystic acne** and carries risks of **antibiotic resistance**.
*PUVA*
- **PUVA (Psoralen plus ultraviolet A)** therapy is a form of photochemotherapy primarily used for severe **psoriasis**, **eczema**, and **cutaneous T-cell lymphoma**.
- It is **not a treatment for acne** and has significant side effects, including increased risk of **skin cancer**.
*Tetracycline*
- **Tetracycline** is an oral antibiotic often used to treat moderate to severe inflammatory acne due to its anti-inflammatory effects and reduction of *P. acnes*.
- While effective for some inflammatory acne, it is typically **less potent than isotretinoin** for severe, **nodulocystic acne** and may not provide a permanent cure.
Newer Therapies in Acne Management Indian Medical PG Question 7: Which of the following is the causative agent for acne fulminans?
- A. Staphylococcus aureus
- B. Malassezia furfur
- C. Propionibacterium acnes (Cutibacterium acnes) (Correct Answer)
- D. Streptococcus pyogenes
Newer Therapies in Acne Management Explanation: ***Propionibacterium acnes (Cutibacterium acnes)***
- **Acne fulminans** is a severe, ulcerative form of acne that is considered an **autoinflammatory syndrome** rather than a simple bacterial infection
- While the exact etiology remains unclear, ***Cutibacterium acnes*** (formerly *Propionibacterium acnes*) plays a significant role in the pathophysiology
- It is believed that acne fulminans may result from a **hypersensitivity reaction to *C. acnes* antigens** or an exaggerated immune response to the bacterium
- *C. acnes* is the **most relevant microorganism** associated with all forms of acne, including acne vulgaris and severe variants like acne fulminans
- Treatment often includes systemic corticosteroids (to control inflammation) combined with isotretinoin
*Staphylococcus aureus*
- *Staphylococcus aureus* causes **bacterial skin infections** such as folliculitis, impetigo, furuncles, and cellulitis
- While secondary bacterial superinfection with *S. aureus* can complicate acne lesions, it is **not the primary organism** associated with acne fulminans
*Malassezia furfur*
- *Malassezia furfur* (now classified as *Malassezia globosa* or *M. restricta*) is a **yeast** that causes **pityriasis versicolor** and **Malassezia folliculitis** (also called fungal acne or pityrosporum folliculitis)
- It is **not involved** in the pathogenesis of acne vulgaris or acne fulminans
*Streptococcus pyogenes*
- *Streptococcus pyogenes* is a common cause of **streptococcal infections** including pharyngitis, impetigo, erysipelas, and cellulitis
- It is **not associated** with acne or acne fulminans pathogenesis
Newer Therapies in Acne Management Indian Medical PG Question 8: A patient presented with oily skin and acne formation primarily on the face. Multiple enlarged glands were noted on examination. What is the etiopathogenesis of the disease process?
- A. Septal deviation of nose
- B. Mucous gland hypertrophy
- C. Sweat gland hypertrophy
- D. Sebaceous gland hypertrophy (Correct Answer)
Newer Therapies in Acne Management Explanation: ***Sebaceous gland hypertrophy***
- **Oily skin (seborrhea)** and **acne formation** are directly linked to increased activity and size of the sebaceous glands.
- Hypertrophied sebaceous glands produce excessive **sebum**, which clogs pores and creates a favorable environment for **Cutibacterium acnes** (formerly *Propionibacterium acnes*), leading to acne.
*Septal deviation of nose*
- **Septal deviation** is a structural abnormality within the nose, primarily affecting breathing and potentially leading to snoring or nosebleeds.
- It has no direct etiopathogenic link to **acne** or **oily skin**.
*Mucous gland hypertrophy*
- **Mucous gland hypertrophy** typically occurs in conditions like chronic bronchitis, leading to increased mucus production in the respiratory tract.
- It is unrelated to **skin oiliness** or **acne vulgaris**.
*Sweat gland hypertrophy*
- **Sweat gland hypertrophy** would primarily result in excessive sweating (**hyperhidrosis**).
- While sweat glands contribute to skin moisture, their hypertrophy does not directly cause the **oily appearance** or **acne breakouts** described.
Newer Therapies in Acne Management Indian Medical PG Question 9: Which of the following are treatment options for acne vulgaris?
- A. Isotretinoin
- B. All of the options (Correct Answer)
- C. Topical erythromycin
- D. Oral Minocycline
Newer Therapies in Acne Management Explanation: ***All of the options***
- All listed options (Isotretinoin, Topical erythromycin, and Oral Minocycline) are well-established and commonly used **treatment options for acne vulgaris**, depending on the severity and type of acne.
- The choice of treatment often follows a stepped approach, starting with topical agents for mild to moderate acne and progressing to oral medications like antibiotics or isotretinoin for more severe or resistant cases.
*Isotretinoin*
- **Isotretinoin** is a powerful oral retinoid primarily used for **severe, recalcitrant nodular acne** that has not responded to other treatments.
- It works by reducing sebum production, follicular hyperkeratinization, inflammation, and the growth of *P. acnes*.
*Topical erythromycin*
- **Topical erythromycin** is an **antibiotic** used to treat mild to moderate inflammatory acne by reducing the growth of *Cutibacterium acnes* (formerly *Propionibacterium acnes*) and decreasing inflammation.
- It is often combined with other topical agents like benzoyl peroxide to minimize the development of **antibiotic resistance**.
*Oral Minocycline*
- **Oral minocycline** is a **tetracycline antibiotic** used for moderate to severe inflammatory acne.
- It reduces bacterial populations on the skin and exhibits **anti-inflammatory properties**, making it effective for widespread or deeper lesions.
Newer Therapies in Acne Management Indian Medical PG Question 10: A 40 year old woman presents with a 2 year history of erythematous papulopustular lesions on convexities of the face. There is a background of erythema & telangiectasia. The most likely diagnosis is –
- A. Polymorphic light eruption
- B. Acne vulgaris
- C. Acne rosacea (Correct Answer)
- D. SLE
Newer Therapies in Acne Management Explanation: ***Acne rosacea***
- This condition presents with **erythematous papulopustular lesions**, background **erythema**, and **telangiectasias** predominantly on the convexities of the face, which is a classic presentation for rosacea.
- The absence of **comedones** (blackheads/whiteheads) helps differentiate it from acne vulgaris.
*Polymorphic light eruption*
- This is a recurring skin rash triggered by **sun exposure**, presenting as itchy papules, plaques, or vesicles, usually appearing a few hours after exposure.
- Unlike rosacea, it does not typically feature permanent facial erythema or telangiectasias and is more directly linked to UV exposure episodes.
*Acne vulgaris*
- While it features papules and pustules, **acne vulgaris** is characterized by the presence of **comedones** (blackheads and whiteheads), which are not described in the patient's presentation.
- It also does not typically involve the prominent background erythema and telangiectasias seen in rosacea.
*SLE*
- Systemic lupus erythematosus (SLE) can cause a **malar or 'butterfly' rash** across the nose and cheeks, but it is typically a fixed erythema, sometimes with scaling, and does not usually involve papulopustular lesions or telangiectasias as a primary feature.
- SLE often has systemic symptoms (e.g., joint pain, fatigue) that are not mentioned, and skin lesions can be photosensitive but are not typically pustular.
More Newer Therapies in Acne Management Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
